Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences Limited
02 1Dr.Reddy's Laboratories Limited
03 1SCI Pharmtech, Inc.
04 1Aurobindo Pharma Limited
05 1Cadila Pharmaceuticals Limited
06 1Eli Lilly Kinsale Limited
07 1Glenmark Life Sciences Limited
08 1HETERO LABS LIMITED
09 1Hetero Labs Limited
10 1Honour Lab Limited
11 1MSN Organics Private Limited
12 1MSN Pharmachem Private Limited
13 1MYLAN LABORATORIES LIMITED
14 1Macleods Pharmaceuticals Limited
15 1SICOR Societa' Italiana Corticosteroidi s.r.l.
16 1Tianish Laboratories Private Limited
17 1Unichem Laboratories Limited, India
18 1Zydus Lifesciences Limited
01 3ATOMOXETINE HYDROCHLORIDE
02 1Atomoxetine HCl
03 13Atomoxetine Hydrochloride
04 1Atomoxetine hydrochloride
01 14India
02 1Italy
03 1Taiwan
04 2U.S.A
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 76072-1011
Start Marketing Date : 2017-06-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-071
Start Marketing Date : 2005-06-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
NDC Package Code : 68108-0772
Start Marketing Date : 2018-08-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63419-0440
Start Marketing Date : 2008-10-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 33342-602
Start Marketing Date : 2024-02-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50370-0010
Start Marketing Date : 2010-04-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 50379-0018
Start Marketing Date : 2015-10-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48292-0043
Start Marketing Date : 2023-08-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53747-059
Start Marketing Date : 2018-09-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-665
Start Marketing Date : 2015-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Atomoxetine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atomoxetine Hydrochloride, including repackagers and relabelers. The FDA regulates Atomoxetine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atomoxetine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atomoxetine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atomoxetine Hydrochloride supplier is an individual or a company that provides Atomoxetine Hydrochloride active pharmaceutical ingredient (API) or Atomoxetine Hydrochloride finished formulations upon request. The Atomoxetine Hydrochloride suppliers may include Atomoxetine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Atomoxetine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atomoxetine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atomoxetine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atomoxetine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atomoxetine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atomoxetine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atomoxetine Hydrochloride suppliers with NDC on PharmaCompass.
We have 16 companies offering Atomoxetine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?